Proton Radiotherapy for Recurrent Tumors

Completed · Not applicable

Conditions studied: Tumors

In brief

The purpose of this study is to determine the feasibility of using proton radiotherapy for reirradiation of recurrent malignancies.

Key facts

Study ID

NCT01126476

Run by

Abramson Cancer Center at Penn Medicine

People needed

24

Starts

2010-02-01

Expected to finish

2020-04-01

Last updated by the study team

2020-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with histologically confirmed, non-CNS solid malignancies who have been previously radiated and have a tumor recurrence in or near prior radiation fields. Re-biopsy of the recurrence is not required and left to the discretion of the treating physician, although every effort should be made to confirm recurrence.
• Patients must have a Karnofsky Performance Status of 60. Life expectancy of 3 months .
• Age greater or equal to 18.
• Patients must be able to provide informed consent.
• Women of child bearing potential as long as she agrees to use a recognized method of birth control (e.g. oral contraceptive, IUD, condoms or other barrier methods, etc.)
• Hysterectomy or menopause must be clinically documented.

You may not qualify if…

• Prior radiation treatment less than 3 months from planned start of re-irradiation of any part of the intended treatment volume.
• Pregnant women, women planning to become pregnant and women that are nursing.
• Actively being treated on any research study.

Where it is running

• ProCure Proton Therapy Center — Warrenville, Illinois, United States
• Procure — Oklahoma City, Oklahoma, United States
• Abamson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.